Abstract
With aging of HIV populations, there is concern that Alzheimer’s disease (AD) may become prevalent and difficult to distinguish from HIV-associated neurocognitive disorders. To date, there are no reports documenting histologically verified Alzheimer’s neuropathology in individuals with HIV and dementia. Herein, we report two antiretroviral-treated, virally suppressed, HIV-infected individuals autopsied by the Manhattan HIV Brain Bank. Subject A presented to study at 52 years, already dependent in instrumental activities of daily living (ADLs), with severe cognitive impairment inclusive of learning and memory dysfunction. Her history was significant for educational disability and head trauma. She had rapid cognitive decline and, by death at age 59 years, was bed-bound, incontinent, and non-communicative. At autopsy, she exhibited severe AD neuropathologic change (NIA-AA score A3B3C3) and age-related tau astrogliopathy (ARTAG). She was homozygous for APOE ε3/ε3. No HIV DNA was detected in frontal lobe by nested polymerase chain reaction. Subject B was a community dwelling 81-year-old woman who experienced sudden death by pulmonary embolus. Prior to death, she was fully functional, living independently, and managing all ADLs. At autopsy, she displayed moderate amyloid and severe tau AD neuropathologic changes (A2B3C2), ARTAG, and cerebral congophilic angiopathy. She was an APOE ε3/ε4 heterozygote, and HIV DNA, but not RNA, was detected in frontal lobe, despite 20 years of therapy-induced viral suppression. We conclude that in the setting of HIV, AD neuropathology may occur with or without symptomatic cognitive dysfunction; as with seronegative individuals, there are likely to be complex factors in the generation of clinically relevant impairments.
Similar content being viewed by others
References
Achim CL, Adame A, Dumaop W, Everall IP, Masliah D, HNRC (2009) Increased accumulation of intraneuronal amyloid B in HIV-infected patients. J NeuroImmune Pharmacol 4:190–199
Albert J, Fenyo EM (1990) Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J Clin Microbiol 28(7):1560–1564
Ances B, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DM, Morris JC, Clifford DB (2012) 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol 69(1):72–77
Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2006) Accelerated tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 111:529–538
Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JSK (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73:1982–1987
Crystal HA, Schneider JA, Bennett DA, Leurgans S, Levine SR (2014) Associations of cerebrovascular and Alzheimer’s disease pathology with brain atrophy. Curr Alzheimer Res 11:309–316
Davis DG, Schmitt FA, Wekstein DR, Markesbery WR (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58(4):376–388
Donohue MC, Sperling RA, Petersen R, Sun CK, Weiner MW, Aisen PS (2017) Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons. JAMA 317(22):2305–2316
Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherner M, Gelman B, Morgello S, Singer E, Grant I, Masliah E, NNTC (2009) Clinicopathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neuro-Oncol 15:360–370
Gilbert MTP, Haselkorn T, Bunce M, Sanchez JJ, Lucas SB, Jewell LD, van Marck E, Worobey M (2007) The isolation of nucleic acids from fixed, paraffin-embedded tissues—which methods are useful when? PLoS One 2(6):e537
Gisslen M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H (2009) Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9:63. https://doi.org/10.1186/1471-2377-9-63
Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407–411
Gupta R, Sen N (2016) Traumatic brain injury: a risk factor for neurodegenerative diseases. Rev Neurosci 27(1):93–100
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, JA MA, Morgello S, Simpson DM, JA MC, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, for the CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087–2096
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, LeBlanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Rivera Mindt M, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol 17:3–16
Heaton RK, Franklin DR, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP, Vaida F, Atkinson JH, Marcotte TD, JA MC, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, Simpson DM, Abramson I, Gamst AC, Fennema-Notestine C, Smith DM, Grant I, for the CHARTER Group (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3):473–480
Heneka MT, Carson MJ, ElKhoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol 14:388–405
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJ (2015) Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313(19):1924–1938
Konomi N, Lebwohl E, Mowbray K, Tattersall I, Zhang D (2002) Detection of mycobacterial DNA in Andean mummies. J Clin Microbiol 40(12):4738–4740
Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, Irwin DJ, Weintraub D, Kim CF, Schuck T, Yousef A, Wagner ST, Suh E, VanDeerlin VM, Lee VMY, Trojanowski JQ (2017) Evaluating the patterns of aging-related tau astrogliopathy unravels novel insights into brain aging and neurodegenerative diseases. J Neuropathol Exp Neurol 76(4):270–288
Lace G, Ince PG, Brayne C, Savva GM, Matthews FE, deSilva R, Simpson JE, Wharton SB (2012) Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort. Dement Geriatr Cogn Disord 34:15–24
McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, Tripodis Y, Crary JF, Bieniek KF, Dams-O’connor K, Alvarez VE, Gordon WA, TBI/CTE group (2016) The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic encephalopathy. Acta Neuropathol 131:75–86
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11
Morgello S, Gelman BB, Kozlowski PB, Masliah E, Cornford M, Vinters HV, Cavert W, Grant I, Singer EJ (2001) The National NeuroAIDS TIssue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol 27:326–335
Mosher KI, Wyss-Coray T (2014) Microglial dysfunction in brain aging and Alzheimer’s disease. Biochem Pharmacol 88:594–604
Nelson PT, Kukull WA, Frosch MP (2010) Thinking outside the box: Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol 69(5):449–454
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, vanderFlier WM, vanBerckel BNM, Scheltens P, Visser PJ (2015) Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA 313(19):1939–1949
Piirainen S, Youssef A, Song C, Kalueff AV, Landreth GE, Malm T, Tian L (2017) Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer’s disease: the emerging role for microglia? Neurosci Biobehav Rev 77:148–164
Rempel HC, Pulliam L (2005) HIV-1 tat inhibits neprilysin and elevates amyloid B. AIDS 19:127–135
Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P, for the Manhattan HIV Brain Bank (2004) Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 62:957–962
SantaCruz KS, Sonnen JA, Pezhouh MK, Desrosiers MF, Nelson PT, Tyas SL (2011) Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. J Neuropathol Exp Neurol 70(10):832–840
Schultz C, Ghebremedhin E, Tredici KD, Rub U, Braak H (2004) High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe. Neurobiol Aging 25:397–405
Serra L, Musicco M, Cercignani M, Torso M, Spano B, Mastropasqua C, Guilietti G, Marra C, Bruno G, Koch G, Caltagirone C, Bozzali M (2015) Cognitive reserve and the risk for Alzheimer’s disease: a longitudinal study. Neurobiol Aging 36:592–600
Serrano-Pozo A, Qian J, Monsell SE, Frosch MP, Betensky RA, Hyman BT (2013) Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the national Alzheimer coordinating center. J Neuropathol Exp Neurol 72(12):1182–1192
Solomon IH, deGirolami U, Chettimada S, Misra V, Singer EJ, Gabuzda D (2017) Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis 17(151):151. https://doi.org/10.1186/s12879-017-2246-7.
Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomki B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL (2012) Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE e4 carriers. AIDS 26:2327–2335
Turner RS, Chadwick M, Horton WA, Simon GL, Jiang X, Esposito G (2016) An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst) 4:1–5
Visser PJ, Tijms B (2017) Brain amyloid pathology and cognitive function: Alzheimer disease without dementia? JAMA 317(22):2285–2287
Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK (2004) Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26(6):759–778
Acknowledgements
The authors thank the staff, patients, and families of the MHBB for their contributions. Tissues from the subjects described herein are available on request from the National NeuroAIDS Tissue Consortium.
Funding
This study is supported in part by NIH grants U24MH100931 (The Manhattan HIV Brain Bank; MHBB), K01DA035725 (Dopamine Neurobiology in HIV-associated cognitive dysfunction and substance use), R01NS095252 (Mechanisms of age-related tauopathy), RO1AG054008 (Regulation of tau expression in Alzheimer disease and aging), and UL1TR001433 (funding the Icahn School of Medicine Clinical Research Center).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study is monitored and approved by the institutional review board of the Icahn School of Medicine at Mount Sinai (ISMMS).
Conflict of interest
Susan Morgello, MD: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health.
Michelle Jacobs, PhD: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health.
Jacinta Murray, BS: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health.
Desiree Byrd, PhD: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health.
Eric Neibart, MD: Has no conflicts to report.
Letty Mintz, ANP: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health.
Gregory Meloni, MSE: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health.
Christina Chon, MS: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health.
John Crary, MD PhD: Receives salary support from grants provided to the Icahn School of Medicine from the National Institutes of Health and support for his research programs from Genentech-Roche.
Electronic supplementary material
ESM 1
(XLSX 10 kb)
Rights and permissions
About this article
Cite this article
Morgello, S., Jacobs, M., Murray, J. et al. Alzheimer’s disease neuropathology may not predict functional impairment in HIV: a report of two individuals. J. Neurovirol. 24, 629–637 (2018). https://doi.org/10.1007/s13365-018-0663-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-018-0663-z